Business and Geographical Reporting Segments (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
Business and Geographical Reporting Segments [Abstract] |
|
Segment Reporting Information by Segment |
The following tables reflect results of operations from our business segments for the periods indicated below (in thousands, except
gross profit %):
Year Ended December 31, 2023 |
|
Dermatology
Recurring Procedures
|
|
|
Dermatology
Procedures Equipment
|
|
|
Total
|
|
Revenues
|
|
$
|
21,530
|
|
|
$
|
11,828
|
|
|
$
|
33,358
|
|
Cost of revenues
|
|
|
8,729
|
|
|
|
6,168
|
|
|
|
14,897
|
|
Gross profit
|
|
|
12,801
|
|
|
|
5,660
|
|
|
|
18,461
|
|
Gross profit %
|
|
|
59.5
|
%
|
|
|
47.9
|
%
|
|
|
55.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocated expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Engineering and product development
|
|
|
1,011
|
|
|
|
306
|
|
|
|
1,317
|
|
Selling and marketing
|
|
|
11,169
|
|
|
|
1,787
|
|
|
|
12,956
|
|
Impairment of goodwill
|
|
|
2,284 |
|
|
|
— |
|
|
|
2,284 |
|
Unallocated expenses
|
|
|
—
|
|
|
|
—
|
|
|
|
10,508
|
|
|
|
|
14,464
|
|
|
|
2,093
|
|
|
|
27,065
|
|
(Loss) income from operations
|
|
|
(1,663
|
)
|
|
|
3,567
|
|
|
|
(8,604
|
)
|
Interest expense
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,640
|
)
|
Interest income
|
|
|
— |
|
|
|
— |
|
|
|
231 |
|
Loss on debt extinguishment
|
|
|
— |
|
|
|
— |
|
|
|
(909 |
) |
(Loss) income before benefit from / (provision for) income taxes
|
|
$
|
(1,663
|
)
|
|
$
|
3,567
|
|
|
$
|
(10,922
|
)
|
Year Ended December 31, 2022 |
|
Dermatology
Recurring Procedures
|
|
|
Dermatology
Procedures Equipment
|
|
|
Total
|
|
Revenues
|
|
$
|
23,025
|
|
|
$
|
13,136
|
|
|
$
|
36,161
|
|
Cost of revenues
|
|
|
8,371
|
|
|
|
6,022
|
|
|
|
14,393
|
|
Gross profit
|
|
|
14,654
|
|
|
|
7,114
|
|
|
|
21,768
|
|
Gross profit %
|
|
|
63.6
|
%
|
|
|
54.2
|
%
|
|
|
60.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocated expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Engineering and product development
|
|
|
672
|
|
|
|
357
|
|
|
|
1,029
|
|
Selling and marketing
|
|
|
13,503
|
|
|
|
1,798
|
|
|
|
15,301
|
|
Unallocated expenses
|
|
|
—
|
|
|
|
—
|
|
|
|
10,087
|
|
|
|
|
14,175
|
|
|
|
2,155
|
|
|
|
26,417
|
|
Income (loss) from operations
|
|
|
479
|
|
|
|
4,959
|
|
|
|
(4,649
|
)
|
Interest expense
|
|
|
—
|
|
|
|
—
|
|
|
|
(926
|
)
|
Interest income
|
|
|
—
|
|
|
|
—
|
|
|
|
89
|
|
Income (loss) before benefit from / (provision for) income taxes
|
|
$
|
479
|
|
|
$
|
4,959
|
|
|
$
|
(5,486
|
)
|
|
Disaggregation of Revenue by Geographical Region |
The following tables present the Company’s revenue disaggregated by geographical region for the years ended December 31, 2023 and 2022 (in
thousands). Domestic refers to revenue from customers based in the United States, and foreign revenue is derived from the Company’s distributors primarily in Asia.
Year Ended December 31, 2023
|
|
Dermatology Recurring Procedures |
|
|
Dermatology Procedures Equipment
|
|
|
Total
|
|
Domestic
|
|
$
|
20,215
|
|
|
$
|
2,813
|
|
|
$
|
23,028
|
|
China
|
|
|
— |
|
|
|
3,340 |
|
|
|
3,340 |
|
Korea
|
|
|
673 |
|
|
|
2,055 |
|
|
|
2,728 |
|
Other foreign
|
|
|
642
|
|
|
|
3,620
|
|
|
|
4,262
|
|
Total
|
|
$
|
21,530
|
|
|
$
|
11,828
|
|
|
$
|
33,358
|
|
Year Ended December 31, 2022
|
|
Dermatology Recurring Procedures |
|
|
Dermatology Procedures Equipment
|
|
|
Total
|
|
Domestic
|
|
$
|
21,585
|
|
|
$
|
2,396
|
|
|
$
|
23,981
|
|
China
|
|
|
195 |
|
|
|
4,556 |
|
|
|
4,751 |
|
Korea
|
|
|
888 |
|
|
|
2,828 |
|
|
|
3,716 |
|
Other foreign
|
|
|
357
|
|
|
|
3,356
|
|
|
|
3,713
|
|
Total
|
|
$
|
23,025
|
|
|
$
|
13,136
|
|
|
$
|
36,161
|
|
|
Depreciation and Amortization by Reportable Segment |
For the years ended December 31, 2023 and 2022, depreciation and amortization by reportable segment were as follows (in thousands):
|
|
Year Ended December 31,
|
|
|
|
2023
|
|
|
2022
|
|
Dermatology recurring procedures
|
|
$
|
4,793
|
|
|
$
|
4,421
|
|
Dermatology procedures equipment
|
|
|
746
|
|
|
|
857
|
|
Unallocated expenses
|
|
|
14
|
|
|
|
15
|
|
Total
|
|
$
|
5,553
|
|
|
$
|
5,293
|
|
|
Total Assets by Reportable Segment |
As of December 31, 2023 and 2022, total assets by reportable segment were as follows (in thousands):
|
|
December 31,
|
|
|
|
2023
|
|
|
2022
|
|
Dermatology recurring procedures
|
|
$
|
28,137
|
|
|
$
|
37,230
|
|
Dermatology procedures equipment
|
|
|
5,507
|
|
|
|
7,890
|
|
Other unallocated assets
|
|
|
8,372
|
|
|
|
7,152
|
|
Total
|
|
$
|
42,016
|
|
|
$
|
52,272
|
|
|